graph Evidence gap map comparisons
avelumab based treatmentanti-PD-(L)1
avelumab plus SoC nivolumab based treatment
Comparator:  vs Standard of Care (SoC);   vs rucaparib; 
Risk of bias:  low;   some concerns;   high;  NA;